1.5. Analysis.
Comparison 1 Antifibrinolytic treatment versus control treatment with or without placebo, Outcome 5 Rebleeding reported at end of follow‐up: trials with and without ischaemia prevention according to treatment duration.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.